---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-25-051267"
form_type: "8-K"
ticker: "RMTI"
cik: "0001041024"
company_name: "ROCKWELL MEDICAL, INC."
filed_at: "2025-11-12T23:59:59+00:00"
generated_at: "2026-05-16T20:49:30.489969+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Rockwell Medical Q3 net sales fall 44% to $15.9M; net loss of $1.8M vs profit year ago

## Summary
- Net sales $15.9M, down 44% YoY due to largest customer transitioning to another supplier.
- Net loss of $1.8M compared to net income of $1.7M in Q3 2024; Adjusted EBITDA virtually breakeven at $50k.
- Gross margin contracted to 14% (18% excluding restructuring) from 22% a year ago.
- Cash increased to $23.7M from $18.4M at June 30, driven by ATM stock issuance.
- Reaffirms 2025 guidance: net sales $65-70M, gross margin 16-18%, Adjusted EBITDA ($0.5M)-$0.5M.

## SEC filing metadata
- accession: 0001628280-25-051267
- form_type: 8-K
- ticker: RMTI
- cik: 0001041024
- company_name: ROCKWELL MEDICAL, INC.
- filed_at: 2025-11-12T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1041024/000162828025051267/0001628280-25-051267-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1041024/000162828025051267/rmti-20251112.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-25-051267
- JSON: https://secwatch.observer/filing/0001628280-25-051267.json
- Plain text: https://secwatch.observer/filing/0001628280-25-051267.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.